Top Clinical Trials companies in Australia by EBIT

This ranking features the top 4 Clinical Trials companies in Australia ranked by EBIT, totalling a EBIT of USD -4.49 M, for January 15, 2025.

Australia

Clinical Trials
EBIT
#
Name
EBIT
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
ACL.AX

Australian Clinical Labs Limited

1

ACL.AX
USD 27.49 M
June 30, 2024 USD 2.14 0.82%

Australia
2
TLX.AX

Telix Pharmaceuticals Limited

2

TLX.AX
USD 11.05 M
Dec. 31, 2023 USD 15.47 4.25%

Australia
3
ATHE

Alterity Therapeutics Limited

3

ATHE
USD -13.15 M
June 30, 2024 USD 3.31 -4.06%

Australia
4
CU6.AX

Clarity Pharmaceuticals Ltd

4

CU6.AX
USD -29.87 M
June 30, 2024 USD 2.37 1.84%

Australia
Frequently Asked Questions
  • Which Clinical Trials company in Australia has the highest EBIT ?

    The Clinical Trials company in Australia with the highest EBIT is Australian Clinical Labs Limited (ASX: ACL.AX) at USD 27.49 M.

  • Which Clinical Trials company in Australia has the lowest EBIT ?

    The Clinical Trials company in Australia with the lowest EBIT is Clarity Pharmaceuticals Ltd (ASX: CU6.AX) at USD -29.87 M.